Resmed Inc Stock Net Income
| RME Stock | EUR 236.30 2.20 0.92% |
ResMed Inc fundamentals help investors to digest information that contributes to ResMed's financial success or failures. It also enables traders to predict the movement of ResMed Stock. The fundamental analysis module provides a way to measure ResMed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ResMed stock.
ResMed |
ResMed Inc Company Net Income Analysis
ResMed's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current ResMed Net Income | 779.44 M |
Most of ResMed's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ResMed Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, ResMed Inc reported net income of 779.44 M. This is 128.38% higher than that of the Healthcare sector and significantly higher than that of the Medical Instruments & Supplies industry. The net income for all Germany stocks is 36.51% lower than that of the firm.
ResMed Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ResMed's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ResMed could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics of similar companies.ResMed is currently under evaluation in net income category among its peers.
ResMed Fundamentals
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 31.17 B | |||
| Shares Outstanding | 146.91 M | |||
| Shares Owned By Insiders | 1.29 % | |||
| Shares Owned By Institutions | 66.53 % | |||
| Price To Earning | 41.49 X | |||
| Price To Book | 9.40 X | |||
| Price To Sales | 8.54 X | |||
| Revenue | 3.58 B | |||
| Gross Profit | 2.06 B | |||
| EBITDA | 1.19 B | |||
| Net Income | 779.44 M | |||
| Cash And Equivalents | 147.13 M | |||
| Cash Per Share | 1.03 X | |||
| Total Debt | 765.33 M | |||
| Debt To Equity | 61.30 % | |||
| Current Ratio | 2.06 X | |||
| Book Value Per Share | 25.45 X | |||
| Cash Flow From Operations | 351.15 M | |||
| Earnings Per Share | 5.17 X | |||
| Price To Earnings To Growth | 1.74 X | |||
| Target Price | 261.67 | |||
| Number Of Employees | 8.16 K | |||
| Beta | 0.47 | |||
| Market Capitalization | 29.28 B | |||
| Total Asset | 5.1 B | |||
| Z Score | 22.8 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.34 % | |||
| Net Asset | 5.1 B | |||
| Last Dividend Paid | 1.72 |
About ResMed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ResMed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ResMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ResMed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in ResMed Stock
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.